PERSPECTA

News from every angle

Results for "Federal Trade Commission"

108 stories found

PoliticsReuters2mo ago

US FTC Probes Rising Fertilizer Prices

The US Federal Trade Commission has launched an investigation into the causes behind the recent surge in fertilizer prices, examining potential anti-competitive practices.

Zuckerberg's courthouse entourage showed up in Meta Ray-Bans
TechnologyAl JazeeraFox NewsBusiness Insider+2YahooTimes of India6mo ago5 sources

Zuckerberg's courthouse entourage showed up in Meta Ray-Bans

Mark Zuckerberg took the stand at the Los Angeles Superior Court. Patrick T. Fallon / AFP via Getty Images Zuckerberg's courthouse entourage showed up in Meta Ray-Bans. The judge warned that anybody recording proceedings with smart glasses could face contempt. Meta's smart glasses are surging. Sales tripled in 2025, the company said. As Mark Zuckerberg was ushered into the Los Angeles Superior Court early on Wednesday morning, one accessory in his entourage stood out: Meta Ray-Ban glasses. Zuckerberg, wearing a navy blue suit and tie, arrived without any glasses. Flanking either side of him as he walked up to the courthouse were longtime executive assistant Andrea Besmehn and an unidentified man donning Meta's Ray-Ban glasses. Meta declined to comment about the accessory choice. AI-powered smart glasses weren't just a hot accessory in the California sun. They were a hot topic inside the courtroom. The judge presiding over the trial announced that anyone using glasses to record inside the courtroom would be "held in contempt of the court," according to CNBC. This isn't the first trial where Meta's glasses have caused issues. Last year, while Meta battled the Federal Trade Commission's antitrust allegations, New York Times reporter Mike Isaac posted on X (formerly Twitter) that he had been reprimanded by the court for wearing Meta Ray-Bans. do not wear camera glasses in federal buildings folks 😞 — rat king 🐀 (@MikeIsaac) April 15, 2025 Andrea Besmehn (left) and an unidentified man donning Meta's Ray-Ban glasses while accompanying Zuckerberg. Frederic J. Brown / AFP via Getty Images; Mike Blake/Reuters The glasses cameo came as Zuckerberg took the stand in a Los Angeles trial accusing major social media companies of building addictive products that harm young users. The case centers on a now-20-year-old plaintiff, identified in court filings as "KGM," who alleged that Instagram and YouTube worsened her depression and suicidal thoughts after she started using the apps as a child. TikTok and Snap have already settled, leaving Meta and Google's YouTube as the remaining defendants in the trial, which could shape similar lawsuits nationwide. The trial underway in Los Angeles is focused on design features that plaintiffs say keep teens scrolling. Zuckerberg's testimony follows an earlier appearance from Instagram chief Adam Mosseri. Meta's Ray Ban smart glasses have become a surprise hit. On the company's earnings call last month, Zuckerberg said that sales of the glasses more than tripled in 2025, and compared the moment to the shift from flip phones to smartphones. Meta has increasingly positioned the glasses as a vehicle for its AI ambitions. In addition to taking pictures and playing music, users can ask questions to Meta AI, Meta's AI assistant, about anything that they're looking at through the glasses. Last week, the New York Times reported that Meta is planning to add facial recognition technology to the glasses. Read the original article on Business Insider

Shein Announces It Is Under FTC Investigation
BusinessYahoo23d ago

Shein Announces It Is Under FTC Investigation

Online fashion retailer Shein has disclosed that it is currently under investigation by the Federal Trade Commission (FTC). The nature of the investigation was not immediately detailed, but it marks a significant regulatory development for the company.

Trump Administration Ends Medicare Drug Subsidies, Bans Chinese Robots and Inverters
TechnologybloombergNYTFT+48wapoThe GuardianNPRcnbcfazaftonbladetDWle-figaro+40 more24d ago51 sources

Trump Administration Ends Medicare Drug Subsidies, Bans Chinese Robots and Inverters

The Trump administration announced plans to end subsidies for Medicare Part D drug premiums, which is expected to lead to higher costs for most enrollees. Concurrently, the US also banned the import of new Chinese humanoid robots and power inverters, citing security concerns in its latest tech crackdown.

Financeseeking-alpha4mo ago

FTC Sues StubHub Over Hidden Fees

The Federal Trade Commission has filed a lawsuit against StubHub, alleging that the ticket resale platform engages in deceptive practices by not disclosing mandatory fees upfront.

Medical Groups Sue FTC Over Probe Into Gender Dysphoria Treatments
Politicszerohedge6mo ago

Medical Groups Sue FTC Over Probe Into Gender Dysphoria Treatments

Medical Groups Sue FTC Over Probe Into Gender Dysphoria Treatments Authored by Zachary Stieber via The Epoch Times (emphasis ours), Two medical groups on Feb. 17 sued the federal government over its probe into the organizations’ recommendations for children with gender dysphoria, or the belief that they are a different gender. The Federal Trade Commission (FTC) in Washington on Aug. 6, 2024. Madalina Vasiliu/The Epoch Times The American Academy of Pediatrics and the Endocrine Society said in separate lawsuits filed in federal court in the District of Columbia that the Federal Trade Commission (FTC) is unconstitutionally targeting the groups over their speech. “Using the threat of investigation or prosecution against an organization in order to silence speech the government does not like is retaliation, prohibited by the First Amendment to the U.S. Constitution,” the American Academy of Pediatrics, which says it represents 67,000 pediatricians, said in its lawsuit. “Moreover, issuing an overbroad subpoena as a tool to compel disclosures in such a retaliatory action violates the Fourth Amendment.” The academy said in a 2018 statement, reaffirmed in 2023, that pediatricians could give drugs such as puberty blockers to children who identify as a gender different from their birth sex. FTC officials in a civil demand in January requested details on how the academy came up with the position, as well as each type of pediatric gender dysphoria treatment the academy had advertised or promoted, and whether there were any financial relationships between the organization and companies or doctors that treat gender dysphoria. Officials demanded similar information from the Endocrine Society, a nonprofit that promotes hormone science research and says it has 18,000 members. The society in 2017 said that people who have gender dysphoria or gender incongruence need “a safe and effective hormone regimen that will (1) suppress endogenous sex hormone secretion determined by the person’s genetic/gonadal sex and (2) maintain sex hormone levels within the normal range for the person’s affirmed gender.” FTC officials said in the demand letters that they are investigating whether false or unsubstantiated representations were made concerning the marketing and advertising of treatments for pediatric gender dysphoria. Federal law prohibits people from engaging in deceptive practices affecting commerce and disseminating false advertisements. The probe targets the Endocrine Society over speech that “reflects pure scientific opinion,” the society said in its legal challenge. If allowed to proceed, the investigation would “endanger the ability of organizations to share information and opinion on any issue, be that vaccine safety and efficacy, environmental health risks, emerging infectious diseases, or gender dysphoria,” it added later. The groups want judges to declare that the civil demands violated the First Amendment. Judges should immediately and permanently bar FTC officials from taking action against the groups over their treatment guidelines and any other statements concerning “gender affirming care,” the groups also said. The Epoch Times reached out to the FTC for comment but did not receive a response by the time of publication. Tyler Durden Thu, 02/19/2026 - 17:00